Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR-NK”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT06358430
What this trial is testing

Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD)

Who this might be right for
Colorectal CancerMinimal Residual Disease
M.D. Anderson Cancer Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT07467863
What this trial is testing

Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung CancerAdvanced/Metastatic NSCLC
Beijing Biotech 48
Testing effectiveness (Phase 2)Looking for participantsNCT06930651
What this trial is testing

A Phase I/II Study of CAR.70-Engineered IL15-Transduced Cord Blood-Derived NK Cells With TGF-beta Receptor 2 (TGFBR2) Knock Out in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Myeloid Malignancies

Who this might be right for
Myeloid Malignancies
M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Early research (Phase 1)UnknownNCT05507593
What this trial is testing

Study of DLL3-CAR-NK Cells in the Treatment of Extensive Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive Stage
Tianjin Medical University Cancer Institute and Hospital 18
Testing effectiveness (Phase 2)Looking for participantsNCT07480954
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more
Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT05654038
What this trial is testing

Universal CD19-Targeted UCAR-NK Cells Combined With HSCT for B Cell Hematologic Malignancies

Who this might be right for
B-Cell Lymphoblastic Leukemia/Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China 30
Testing effectiveness (Phase 2)UnknownNCT06242249
What this trial is testing

Anti-BCMA CAR-NK Therapy in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma, Refractory
Shahid Beheshti University of Medical Sciences 10
Early research (Phase 1)Looking for participantsNCT07579208
What this trial is testing

A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma

Who this might be right for
Phase 1NK CellIL13Ra+4 more
M.D. Anderson Cancer Center 36
Early research (Phase 1)Looking for participantsNCT07551336
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
Malignant GliomaHigh-Grade GliomasGlioblastoma+2 more
Beijing Biotech 36
Testing effectiveness (Phase 2)Looking for participantsNCT07551362
What this trial is testing

Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer

Who this might be right for
Advanced Gastric AdenocarcinomaAdvanced Gastroesophageal Junction Adenocarcinoma
Beijing Biotech 36
Very early researchUnknownNCT03692637
What this trial is testing

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Allife Medical Science and Technology Co., Ltd. 30
Testing effectiveness (Phase 2)Temporarily pausedNCT07377526
What this trial is testing

TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 37
Early research (Phase 1)Looking for participantsNCT07480941
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

Who this might be right for
GlioblastomaHigh-grade GliomaMalignant Glioma+2 more
Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT02274584
What this trial is testing

CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)

Who this might be right for
Lymphomas
Peking University 20
Very early researchUnknownNCT04264078
What this trial is testing

Anti-CD7 U-CAR-T Cell Therapy for T/NK Cell Hematologic Malignancies

Who this might be right for
T-cell LeukemiaT-cell Lymphoma
Xinqiao Hospital of Chongqing 30
Early research (Phase 1)Not Yet RecruitingNCT07358988
What this trial is testing

KN5501 Cell Injection for Refractory SLE(CLEAR)

Who this might be right for
Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD 36
Very early researchUnknownNCT04639739
What this trial is testing

Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma.

Who this might be right for
NHL
Xinqiao Hospital of Chongqing 9
Very early researchUnknownNCT06478459
What this trial is testing

Endoscopic Ultrasound (EUS) Intratumoral Injection of CAR-NK Cells in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Non-resectable
Zhejiang University 20
Very early researchUnknownNCT03690310
What this trial is testing

Study of Anti-CD19 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma

Who this might be right for
Refractory B-Cell Lymphoma
Allife Medical Science and Technology Co., Ltd. 9
Next Page